New York University Langone Hospital - Long Island — Mineola, New York

New York University Langone Hospital - Long Island is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

New York University Langone Hospital - Long Island has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, HER2-positive Breast Cancer, Myelodysplastic Syndromes.

Sponsors: Dana-Farber Cancer Institute, Taiho Oncology, Inc., Longboard Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University Langone Hospital - Long Island?

New York University Langone Hospital - Long Island has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University Langone Hospital - Long Island conducted?

New York University Langone Hospital - Long Island has 4 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, HER2-positive Breast Cancer, Myelodysplastic Syndromes.

Is New York University Langone Hospital - Long Island accredited by Crixeo Health?

Yes — New York University Langone Hospital - Long Island holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York University Langone Hospital - Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.